<DOC>
	<DOCNO>NCT00954057</DOCNO>
	<brief_summary>This pilot study determine safety efficacy orbital injection LIPO-102 .</brief_summary>
	<brief_title>Pilot Study Determine Safety Efficacy Orbital Injections LIPO-102 Patients With Symptomatic Exophthalmos Associated With Thyroid-related Eye Disease ( TED )</brief_title>
	<detailed_description />
	<mesh_term>Thyroid Diseases</mesh_term>
	<mesh_term>Eye Diseases</mesh_term>
	<mesh_term>Exophthalmos</mesh_term>
	<criteria>Male Non pregnant female Symptomatic exophthalmos Inactive Thyroid Eye Disease Signed informed consent Known hypersensitivity study drug Treatment investigational agent within 30 day first dose History Thyroid Eye Disease le 6 month Previous decompression surgery Glaucoma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>TED</keyword>
</DOC>